It was a perfect storm of problems for the medical-equipment manufacturer.
News & Analysis: ViewRay, Inc.
Shares continue to rebound after an SEC filing reveals that an insider has been quietly adding to his position.
Momentum carried one of these stocks higher, while two others bounced back from tough hits recently.
Shares start to rebound after a gut-wrenching decline.
VRAY earnings call for the period ending June 30, 2019.
Traders are fleeing after the company reports mixed second-quarter results and slashes full-year guidance.
Here's why ViewRay, Nevro, and LaMaitre Vascular could all be great healthcare stocks to own.
First-quarter results missed the mark, but traders are feeling upbeat because this company's backlog continues to grow.
VRAY earnings call for the period ending March 31, 2019.
VRAY earnings call for the period ending December 31, 2018.